MENU
TCRT
AS OF
Dec 24 closing price
Price
$3.52
Change
+$0.12 (+3.53%)
Capitalization
7.86M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
TCRT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alaunos Therapeutics (TCRT) Ownership - Who owns Alaunos Therapeutics?

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.86M
P/E Ratio
N/A
Total Cash
1.94M
Projected Growth
N/A
Total Debt
N/A
Revenue
6K
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash/Share
0.87
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

TCRT
Capitalization
7.86M
P/E Ratio
N/A
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash
1.94M
Total Cash/Share
0.87
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
6K
ROE
N/A
Book Value
2.8M
P/B Ratio
2.80
Cash Flow
N/A
Earnings
-2.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
2.92
Current Revenue Per Employee
2000.00
Dividends Per Share - Security
N/A
EBITDA
-3.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-110.67
Shares Held By Institutions
289K
Shares Outstanding - Current
2.23M
Total Liabilities
921K
Total Volume MTD
N/A
Value
-1
Gain YTD
84.777
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TCRT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for TCRT
A.I. Advisor
published General Information

General Information

a cancer treatment company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com